Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combi-elastography Assessment of Chronic Liver Disease Multi-center Study

NCT04625166 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04625166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combi-elastography Assessment of Chronic Liver Disease Multi-center Study
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2020
Completion date
June 30, 2022
Enrollment
880 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced liver injury, hepatitis b, non alcoholic fatty liver